WOBURN, Mass.--(BUSINESS WIRE)--Cambria Biosciences today unveiled a novel approach to discovering epilepsy drugs by utilizing an intact animal nervous system engineered for high-throughput
For more information, please visit
http://home.businesswire.com/portal/site[...]=en&ndmConfigId=1001385&vnsId=